According to IMARC Group’s latest report, titled “Artificial Intelligence in Healthcare Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” Offers a comprehensive analysis of the industry, which comprises insights on global artificial intelligence in healthcare market.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The global artificial intelligence in healthcare market reached a value of US$ 3.4 Billion in 2021. Artificial intelligence (AI) in healthcare is used for evaluating the symptoms and patterns of diseases to offer better support, guidance, feedback, etc., to healthcare providers. It utilizes various software programs with complex algorithms that replicate human senses in the analysis, interpretation, and comprehension of medical data. In addition to this, systems equipped with AI can provide digital consultations, cost-effective drug creation, management facilities, etc., and track health status via smart wearable devices.
Request Free Sample Report: https://www.imarcgroup.com/artifical-intelligence-healthcare-market/requestsample
The increasing utilization of robots for surgical and rehabilitation procedures is primarily driving the artificial intelligence in healthcare market. Additionally, the widespread adoption of numerous advanced technologies, such as AI in medical devices and systems for convenient and secure management of data, generating patient-specific information, providing clinical diagnosis, etc., is further catalyzing the market growth. Besides this, the emerging trend of digitalization in the healthcare sector is acting as another significant growth-inducing factor. Moreover, the expanding geriatric population and the growing integration of artificial intelligence in smart devices for assisted living, fall detection, virtual companions, etc., are also positively influencing the global market. Apart from this, the launch of several favorable policies by government bodies across countries to improve the AI infrastructures and the rising investments in R&D activities are anticipated to fuel the artificial intelligence in healthcare market over the forecasted period. Looking forward, IMARC Group expects the market to reach US$ 18.7 Billion by 2027, exhibiting a CAGR of 31.23% during 2022-2027.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/artifical-intelligence-healthcare-market
List of Key Companies Covered in this Market Report:
- Amazon Web Services Inc.
- Cloudmedx Inc.
- DeepMind, Enlitic Inc.
- General Vision Inc.
- Google Inc.
- International Business Machines
- iCarbonX, Intel Corporation,
- Micron Technology Inc.
- Microsoft Corporation
- Next It Corporation
- Nuance Communications Inc.
- Nvidia Corporation
- Siemens Healthcare
- Welltok Inc.
The report has segmented the market on the basis of offering, technology, application, end user and geography.
Breakup by Offering:
Breakup by Technology:
- Machine Learning
- Context-Aware Computing
- Natural Language Processing
Breakup by Application:
- Robot-Assisted Surgery
- Virtual Nursing Assistant
- Administrative Workflow Assistance
- Fraud Detection
- Dosage Error Reduction
- Clinical Trial Participant Identifier
- Preliminary Diagnosis
Breakup by End-User:
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800